Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin–eosin-based morphologic parameters from the WHO classification

Björn Konukiewitz(University Hospital Schleswig-Holstein), Moritz Jesinghaus(Philipps University of Marburg), Markus Tschurtschenthaler(TUM Klinikum), Kathrin Halfter(Ludwig-Maximilians-Universität München), Dirk Wilhelm(TUM Klinikum), Miguel G. Silva(TUM Klinikum), Junika Pohl(Technical University of Munich), Wilko Weichert(Deutsches Konsortium für Translationale Krebsforschung), Nicole Pfarr(Technical University of Munich), Anna Melissa Schlitter(German Cancer Research Center), Sebastian Foersch(Johannes Gutenberg University Mainz), Maxime Schmitt(Philipps University of Marburg), Corinna Lang(Technical University of Munich), Katja Steiger(Technical University of Munich), Jutta Engel(Universidad de Granada), Melanie Boxberg(Starnberg Hospital)
British Journal of Cancer
October 6, 2021
Cited by 43


Related Papers